A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Yazar: | Shehab, Habibul Mohsin |
---|---|
Diğer Yazarlar: | Yasmin, Hasina |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2024
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/22683 |
Benzer Materyaller
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Yazar:: Tabassum, Nadira
Baskı/Yayın Bilgisi: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Yazar:: Mahee, Sadique Abdal
Baskı/Yayın Bilgisi: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Yazar:: Alim, Abdul
Baskı/Yayın Bilgisi: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Yazar:: Karmaker, Swastika
Baskı/Yayın Bilgisi: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2023)